JAMIESON WELLNESS INC (JWEL.CA) Forecast, Price Target & Analyst Ratings
TSX:JWEL • CA4707481046
35.74 CAD
-0.76 (-2.08%)
Last: Mar 6, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for JAMIESON WELLNESS INC (JWEL.CA).
Forecast Snapshot
Consensus Price Target
CA$44.71
+ 25.10% Upside
Next Earnings Forecast
Release DateMay 6, 2026
PeriodQ4 / 2025
EPS EstimateCA$0.93
Revenue Estimate280.53M
ChartMill Buy Consensus
81.67%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
CA$44.71
Upside
+ 25.10%
From current price of CA$35.74 to mean target of CA$44.71, Based on 12 analyst forecasts
Low
CA$42.42
Median
CA$44.37
High
CA$48.30
Price Target Revisions
1 Month
2.14%
3 Months
2.11%
Price Target Summary
12 analysts have analysed JWEL.CA and the average price target is 44.71 CAD. This implies a price increase of 25.1% is expected in the next year compared to the current price of 35.74.
The average price target has been revised upward by 2.11% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
81.67%
JWEL.CA was analyzed by 12 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about JWEL.CA.
In the previous month the buy percentage consensus was at a similar level.
JWEL.CA was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-11-07 | Canaccord Capital | Downgrade | |
| 2022-11-04 | RBC Royalbank | Downgrade | Outperform |
| 2022-11-04 | TD Research | Maintains | Buy |
| 2022-11-04 | CIBC Capital Markets | Downgrade | Outperform |
| 2022-11-04 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-10-31 | CIBC Capital Markets | Maintains | Outperform |
| 2022-08-29 | TD Research | Upgrade | Action List Buy |
| 2022-08-05 | RBC Royalbank | Downgrade | Outperform |
| 2022-08-05 | BMO Financial | Maintains | Outperform |
| 2022-08-05 | CIBC Capital Markets | Upgrade | Outperform |
| 2022-08-05 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-06-03 | RBC Royalbank | Upgrade | Outperform |
| 2022-06-02 | National Bank of Canada Financial | Upgrade | Outperform |
| 2022-06-02 | TD Research | Upgrade | Buy |
| 2022-06-02 | CIBC Capital Markets | Upgrade | Outperform |
| 2022-06-02 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-06-02 | Eight Capital | Upgrade | Buy |
| 2022-05-09 | BMO Financial | Upgrade | Market Perform |
| 2022-05-06 | CIBC Capital Markets | Maintains | Outperform |
| 2022-05-06 | Scotiabank Capital | Maintains | Sector Perform |
| 2022-04-28 | CIBC Capital Markets | Maintains | Outperform |
| 2022-02-25 | RBC Royalbank | Downgrade | Outperform |
| 2022-02-25 | CIBC Capital Markets | Downgrade | Outperform |
| 2022-02-25 | Scotiabank Capital | Downgrade | Sector Perform |
| 2022-01-21 | TD Research | Upgrade | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 6, 2026
PeriodQ4 / 2025
EPS EstimateCA$0.93
Revenue Estimate280.53M
Revenue Q2Q14.60%
EPS Q2Q16.34%
Number of Analysts6
Next Earnings Revisions
Revenue (1 Month)
0.26%
Revenue (3 Months)
0.26%
EPS (1 Month)
0.55%
EPS (3 Months)
-0.82%
Next Earnings Summary
JWEL.CA is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 0.93 CAD and the consensus revenue estimate is 280.53M CAD.
The next earnings revenue estimate has been revised upward by 0.26% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 547.369M 21.36% | 676.172M 23.53% | 733.78M 8.52% | 836.97M 14.06% | 926.24M 10.67% | 1.011B 9.15% | N/A | N/A | N/A | |
| EBITDA YoY % growth | 118.058M 25.03% | 137.68M 16.62% | 130.162M -5.46% | 162.8M 25.07% | 185.4M 13.88% | 207.6M 11.97% | 227.6M 9.63% | 232.72M 2.25% | 247.51M 6.36% | |
| EBIT YoY % growth | 100.81M 25.78% | 117.357M 16.41% | 111.63M -4.88% | 134.33M 20.34% | 158.41M 17.93% | 177.68M 12.16% | 199.94M 12.53% | 212.88M 6.47% | 224.81M 5.60% | |
| Operating Margin | 18.42% | 17.36% | 15.21% | 16.05% | 17.10% | 17.57% | N/A | N/A | N/A | |
| EPS YoY % growth | 1.54 14.93% | 1.55 0.65% | 1.61 3.87% | 1.90 17.84% | 2.38 25.38% | 2.71 14.07% | N/A | N/A | N/A |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.93 16.34% | 0.10 -27.14% | 0.47 17.30% | 0.52 26.88% | 1.07 15.07% |
| Revenue Q2Q % growth | 280.53M 14.60% | 165.65M 13.49% | 226.82M 13.92% | 221.18M 10.96% | 305.95M 9.06% |
| EBITDA Q2Q % growth | 68.692M -6.06% | 15.81M 0.51% | 40.494M 7.19% | 46.308M 1.59% | 76.5M 11.37% |
| EBIT Q2Q % growth | 61.404M 12.47% | 9.078M -17.28% | N/A | N/A | N/A |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
19.00%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
10.13%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
21.31%
EBIT Next 5 Year
14.89%
JAMIESON WELLNESS INC / JWEL.CA Forecast FAQ
What is the average price target for JAMIESON WELLNESS INC (JWEL.CA) stock?
12 analysts have analysed JWEL.CA and the average price target is 44.71 CAD. This implies a price increase of 25.1% is expected in the next year compared to the current price of 35.74.
Can you provide the upcoming earnings date for JAMIESON WELLNESS INC?
JAMIESON WELLNESS INC (JWEL.CA) will report earnings on 2026-05-06.
What are the consensus estimates for JAMIESON WELLNESS INC (JWEL.CA) next earnings?
The consensus EPS estimate for the next earnings of JAMIESON WELLNESS INC (JWEL.CA) is 0.93 CAD and the consensus revenue estimate is 280.53M CAD.
Can you provide the consensus rating for JAMIESON WELLNESS INC stock?
The consensus rating for JAMIESON WELLNESS INC (JWEL.CA) is 81.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.